Skip to content

Supplier News

Reckitt Benckiser discontinues Suboxone Tablets

Reckitt Benckiser Pharmaceuticals Inc. has issued a Citizen Petition with the Food and Drug Administration requesting action to curtail the risk of pediatric exposure with buprenorphine-containing products for the treatment of opioid dependence.

Dream Water to be featured on CNBC show

David Lekach and Vincent Porpiglia, the founders of Dream Water, are slated to be featured on CNBC’s "How I Made My Millions." The sleep aid beverage maker said Lekach and Porpiglia are scheduled to appear on the program on Monday, Sept. 24, at 9:00 pm ET. Dream Water will be highlighted in

Mylan generics ships generics of Diovan, Antivert

Mylan Inc. has released generic versions of Novartis’ Diovan HCT tablets and Pfizer’s Antivert tablets. Mylan said Friday that its Diovan generic, valsartan and hydrochlorothiazide tablets, come in strengths of 80/12.5 mg, 160/12.5 mg, 160/25 mg, 320/12.5 mg and 320/25 mg.

Hershey opens modernized plant

The Hershey Co. has opened the doors for what it calls "the world’s most technologically advanced chocolate making facility" that it said "positions the company for its next 100 years of global growth.

WoundSeal goes over the counter

WoundSeal, a topical powder designed to stop bleeding instantly for the more than 50 million seniors on blood thinners, is now available over the counter.

ProPhase nixes bid to be bought by Matrixx

ProPhase Labs Inc., the maker of Cold-EEZE cold remedies, has rejected an unsolicited bid to be acquired by Matrixx Initiatives Inc., which owns the rival Zicam brand of cold and allergy products.